title: Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications.
abstract: An adult diabetic male with three toes amputated on his right foot presented with an ulcer infection on his left foot, unresponsive to conventional antifungal oral medication for over two months. The ulcerated foot wound had a large impairment on the patient's quality of life, as determined by the Wound-QoL questionnaire. The compounding pharmacist recommended and the physician prescribed two topical compounded medicines, which were applied twice a day, free of charge at the compounding pharmacy. The foot ulcer infection was completely resolved following 13 days of treatment, with no longer any impairment on the patient's quality of life. This scientific case study highlights the value of pharmaceutical compounding in current therapeutics, the importance of the triad relationship, and the key role of the compounding pharmacist in diabetes care.
authors.affiliation: Agbi's Compounding Pharmacy LLC, Pikesville, Maryland. agbiscompoundingpharmacy@yahoo.com.
authors.forename: Kelechi E
authors.initials: KE
authors.lastname: Agbi
authors.affiliation: Professional Compounding Centers of America, Houston, Texas.
authors.forename: Maria
authors.initials: M
authors.lastname: Carvalho
authors.affiliation: Professional Compounding Centers of America, Houston, Texas.
authors.forename: Ha
authors.initials: H
authors.lastname: Phan
authors.affiliation: Professional Compounding Centers of America, Houston, Texas.
authors.forename: Cristiane
authors.initials: C
authors.lastname: Tuma
mesh_terms: D000279:Administration, Cutaneous; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry / Q000191:economics; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry / Q000191:economics; D003022:Clotrimazole / Q000008:administration & dosage; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D017719:Diabetic Foot / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics / Q000382:microbiology; D004338:Drug Combinations; D004339:Drug Compounding; D016527:Drug Costs; D006801:Humans; D007052:Ibuprofen / Q000008:administration & dosage; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage; D010205:Pantothenic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D013997:Time Factors; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry / Q000191:economics; D014803:Vitamin B Complex / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry / Q000191:economics; D014945:Wound Healing / Q000187:drug effects*; D014946:Wound Infection / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics / Q000382:microbiology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000935:Antifungal Agents; D004338:Drug Combinations; D014665:Vasodilator Agents; D014803:Vitamin B Complex; D008795:Metronidazole; D010205:Pantothenic Acid; C007288:dexpanthenol; D003022:Clotrimazole; D009543:Nifedipine; D007052:Ibuprofen